Objective: The paper explores the evaluation objectives, angles and methods that can be used to quantitatively evaluate the quality of drugs in local pharmaceutical centralized volume-based procurement. In addition, based on the concept of value-based health care, a drug quality evaluation index pool is constructed to provide tools for local procurement practice. Methods: We collect local pharmaceutical centralized volume-based procurement documents, identify the indicators that can be used to evaluate the macro quality level of drugs, build a basic index pool, and build a classification index pool based on expert opinions. Results: The basic index pool for drug quality evaluation suitable for local pharmaceutical centralized procurement was established, which was divided into three categories of the recommended index pool, the caution index pool, and the non-recommended index pool. The recommended index pool contains 8 first-level indicators, 17 second-level indicators and 27 third-level indicators. The caution index pool contains 5 first-level indicators, 5 second-level indicators and 5 third-level indicators. The non-recommended index pool contains 9 first-level indicators, 25 second-level indicators and 29 third-level indicators. Conclusion: In the practice of local procurement, the indicators in the recommended index pool can be directly selected. The indicators in the caution index pool can be selected when necessary, or can be used to assist in ranking, and the indicators in the non-recommended index pool are not recommended.
Key words
pharmaceutical centralized volume-based procurement /
value-based health care /
comprehensive evaluation /
drug quality evaluation
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 邵靖,蒋茜,谢晓曦,等.综合评分法在药品集中带量采购中的应用及优化研究[J].现代商贸工业,2023,44(22):28-31.
[2] 陈凯,蒋茜,谢晓曦,等.地方集采综合评分法的价格得分计算公式比较研究[J].中国医疗保险,2022(09):67-72.
[3] 常峰.药品带量采购的核心要素分析[J].中国卫生资源,2021,24(01):15-19.
[4] PORTER M, TEISBERG E.Redefining health care:creating value-based competition on results[M].Cambridge:Harvard Business Review Press,2006.
[5] 金春林,王海银,孙辉,等.价值医疗的概念、实践及其实现路径[J].卫生经济研究,2019,36(02):6-8.
[6] World Health Organization.Operational principles for good pharmaceutical procurement.[EB/OL].(1999-01-01)[2023-11-21].https://iris.who.int/handle/10665/66251.
[7] MANIADAKIS N, HOLTORF AP, OTAVIO CORREA J, et al.Shaping pharmaceutical tenders for effectiveness and sustainability in countries with expanding healthcare coverage[J].Applied health economics and health policy, 2018,16(5):591-607.
[8] NHS England.Procurement, patient choice and competition regulations:guidance[EB/OL].(2013-12-19)[2023-11-21].https://www.gov.uk/government/publications/procurement-patient-choice-and-competition-regulations-guidance.
[9] STILGER P S, SIDERIUS J, RAAIJ E M.Formulas for choosing the most economically advantageous tender-a comparative study[D].Utrecht:Utrecht University, 2012.
